Regencell Bioscience/$RGC

1D1W1MYTD1Y5YMAX

About Regencell Bioscience

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Ticker
$RGC
Sector
Health
Primary listing
NASDAQ
Employees
-
Headquarters
Causeway Bay, Hong Kong
Website
www.regencellbioscience.com

RGC Metrics

BasicAdvanced
$3.1B
-
-$0.01
1.64
-

RGC Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

RGC News

AllArticlesVideos

Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Business Wire2 months ago

Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Business Wire2 months ago

Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member

Accesswire3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.